Study to Determine Racial and Gender Differences in Platelet Aggregation

Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00233428

Enrollment

Registered

2005-10-05

Start date

2005-05-31

Completion date

2006-05-31

Last updated

2015-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet Aggregation

Keywords

Healthy volunteers

Brief summary

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Detailed description

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking. We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Interventions

PROCEDUREBlood Draw

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Race of Caucasian, African American, or Hispanic

Exclusion criteria

* Chronic medical conditions * Tobacco use * Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026